Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
SA Analyst Downgrades: TSLA, AAPL, T, PG, HPE, GILD, LRCX, ARCC
Needham Maintains Buy on Blueprint Medicines, Lowers Price Target to $130
Blueprint Medicines Analyst Ratings
9 Health Care Stocks Whale Activity In Today's Session
Why Is Summit Therapeutics Stock Trading Higher On Monday?
Pfizer Q1 Earnings Preview: Wall Street Expects Y-o-y Declines in Both EPS and Revenue